Crossmark

Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype

Crossref DOI link: https://doi.org/10.1007/s10549-015-3525-x

Published Online: 2015-08-08

Published Print: 2015-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tsai, Kuo-Wang

Li, Guan-Cheng

Chen, Chien-Hsun

Yeh, Ming-Hsin

Huang, Jer-Shyung

Tseng, Hui-Hwa

Fu, Ting-Ying

Liou, Huei-Han

Pan, Hung-Wei

Huang, Sheng-Feng

Chen, Chien-Chou

Chang, Hui-Yu

Ger, Luo-Ping

Chang, Hong-Tai
License Information

Text and Data Mining valid from 2015-08-01